Literature DB >> 8211631

Heller laparoscopic cardiomyotomy with antireflux anterior fundoplication (Dor) in the treatment of esophageal achalasia.

E Ancona1, A Peracchia, G Zaninotto, M Rossi, L Bonavina, A Segalin.   

Abstract

The technique of Heller laparoscopic myotomy with associated Dor anterior fundoplication for the treatment of esophageal achalasia is described. This operation was performed on three patients with clinical, radiologic, and manometric diagnoses of achalasia. Complete relief of dysphagia and modifications of radiological and manometric patterns were achieved in all patients 1 month after surgery. Laparoscopic treatment of achalasia is technically feasible, reduces surgical trauma, and may be considered a valid alternative to open surgery.

Entities:  

Mesh：

Year:  1993        PMID： 8211631     DOI： 10.1007/bf00311744

Source DB:  PubMed          Journal:  Surg Endosc        ISSN： 0930-2794            Impact factor:   4.584


  11 in total

1.  Frontiers in general surgery: pioneers, cowboys and desperados.

Authors:  I R Berman
Journal:  Surg Endosc       Date:  1992 Mar-Apr       Impact factor: 4.584

2.  Thoracoscopic long oesophageal myotomy for nutcracker oesophagus: initial experience of a new surgical approach.

Authors:  S M Shimi; L K Nathanson; A Cuschieri
Journal:  Br J Surg       Date:  1992-06       Impact factor: 6.939

3.  Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients.

Authors:  N Okike; W S Payne; D M Neufeld; P E Bernatz; P C Pairolero; D R Sanderson
Journal:  Ann Thorac Surg       Date:  1979-08       Impact factor: 4.330

Review 4.  Treatment of achalasia and related motor disorders.

Authors:  G Vantrappen; J Hellemans
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

5.  Primary treatment of esophageal achalasia. Long-term results of myotomy and Dor fundoplication.

Authors:  L Bonavina; A Nosadini; R Bardini; M Baessato; A Peracchia
Journal:  Arch Surg       Date:  1992-02

Review 6.  Results of surgical treatment of achalasia of the esophagus.

Authors:  A Csendes
Journal:  Hepatogastroenterology       Date:  1991-12

7.  Laparoscopic Heller cardiomyotomy and thoracoscopic esophageal long myotomy for the treatment of primary esophageal motor disorders.

Authors:  M Anselmino; R A Hinder; C J Filipi; P Wilson
Journal:  Surg Laparosc Endosc       Date:  1993-10

8.  Operation for esophageal achalasia. Results of esophagomyotomy without an antireflux operation.

Authors:  F H Ellis; R E Crozier; E Watkins
Journal:  J Thorac Cardiovasc Surg       Date:  1984-09       Impact factor: 5.209

9.  Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia.

Authors:  A Csendes; I Braghetto; A Henríquez; C Cortés
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

10.  Laparoscopic cardiomyotomy for achalasia.

Authors:  S Shimi; L K Nathanson; A Cuschieri
Journal:  J R Coll Surg Edinb       Date:  1991-06
View more
  31 in total

Review 1.  Data analyses and perspectives on laparoscopic surgery for esophageal achalasia.

Authors:  Kazuto Tsuboi; Nobuo Omura; Fumiaki Yano; Masato Hoshino; Se-Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  The laparoscopic Heller-Dor operation remains an effective treatment for esophageal achalasia at a minimum 6-year follow-up.

Authors:  M Costantini; G Zaninotto; E Guirroli; C Rizzetto; G Portale; A Ruol; L Nicoletti; E Ancona
Journal:  Surg Endosc       Date:  2005-01-10       Impact factor: 4.584

3.  [Technical aspects of laparoscopic Heller myotomy for achalasia].

Authors:  I Gockel; S Timm; T J Musholt; A Rink; H Lang
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

4.  Etiology, diagnosis, and treatment of failures after laparoscopic Heller myotomy for achalasia.

Authors:  Giovanni Zaninotto; Mario Costantini; Giuseppe Portale; Giorgio Battaglia; Daniela Molena; Alessanda Carta; Michela Costantino; Loredana Nicoletti; Ermanno Ancona
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

5.  Gastroesophageal reflux in achalasia. When is reflux really reflux?

Authors:  P F Crookes; S Corkill; T R DeMeester
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  The Impact of Heller Myotomy on Integrated Relaxation Pressure in Esophageal Achalasia.

Authors:  Renato Salvador; Edoardo Savarino; Elisa Pesenti; Lorenzo Spadotto; Giovanni Capovilla; Francesco Cavallin; Francesca Galeazzi; Loredana Nicoletti; Stefano Merigliano; Mario Costantini
Journal:  J Gastrointest Surg       Date:  2015-10-30       Impact factor: 3.452

7.  Laparoscopic Heller myotomy can be used as primary therapy for esophageal achalasia regardless of age.

Authors:  Renato Salvador; Mario Costantini; Francesco Cavallin; Lisa Zanatta; Elena Finotti; Cristina Longo; Loredana Nicoletti; Giovanni Capovilla; Romeo Bardini; Giovanni Zaninotto
Journal:  J Gastrointest Surg       Date:  2013-09-10       Impact factor: 3.452

Review 8.  Therapeutic options in oesophageal dysphagia.

Authors:  Jan Tack; Giovanni Zaninotto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

9.  Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.

Authors:  Giovanni Zaninotto; Vito Annese; Mario Costantini; Alberto Del Genio; Michela Costantino; Magdalena Epifani; Giovanni Gatto; Vittorio D'onofrio; Luigi Benini; Sandro Contini; Daniela Molena; Giorgio Battaglia; Berardino Tardio; Angelo Andriulli; Ermanno Ancona
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

10.  Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial.

Authors:  William O Richards; Alfonso Torquati; Michael D Holzman; Leena Khaitan; Daniel Byrne; Rami Lutfi; Kenneth W Sharp
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.